Table 1.
Topical Treatment | Description | Indication |
---|---|---|
Imiquimod cream [16] | Stimulates immune response against BCC cells | Superficial or low-risk BCCs |
5-fluorouracil (5-FU) [25] | Inhibits cell growth and promotes cell death | Superficial or low-risk BCCs |
Diclofenac gel [30] | Nonsteroidal anti- inflammatory medication | Superficial or low-risk BCCs |
Ingenol mebutate gel [50] | Induces cell death and local immune Response |
Superficial or low-risk BCCs |